76078 Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices 

evaluation of DIDP. On December 20, 

2019, the Agency granted the request, 

and subsequently initiated the scoping 

process for a risk evaluation for this 

category of chemical substances. The 

purpose of a risk evaluation is to 

determine whether a chemical 

substance, or group of chemical 

substances, presents an unreasonable 

risk to health or the environment, under 

the conditions of use, including an 

unreasonable risk to a relevant 

potentially exposed or susceptible 

subpopulation (15 U.S.C. 2605(b)(4)(A)). 

As part of this process, EPA must 

evaluate both hazards and exposures for 

the conditions of use; describe whether 

aggregate or sentinel exposures were 

considered and the basis for 

consideration; not consider costs or 

other nonrisk factors; take into account 

where relevant, likely duration, 

intensity, frequency, and number of 

exposures and describe the weight of 

the scientific evidence for hazards and 

exposures (15 U.S.C. 2605(b)(4)(F)). This 

process will culminate in a 

determination of whether or not the 

category of chemical substances 

presents an unreasonable risk of injury 

to health or the environment under the 

conditions of use (15 U.S.C. 

2605(b)(4)(A); 40 CFR 702.47). 

III. Draft Scope of the Risk Evaluation 

for Di-isodecyl phthalate (DIDP) 

The category of chemical substances 

for which EPA is publishing the draft 

scope of the risk evaluation includes the 

following chemical substances: 1,2- 

benzenedicarboxylic acid, 1,2- 

diisodecyl ester (CASRN 26761–40–0) 

and 1,2-benzenedicarboxylic acid, diC9-11-branched alkyl esters, C10-rich; 

(CASRN 68515–49–1). The draft scope 

of the risk evaluation for this category 

of chemical substances includes the 

conditions of use, hazards, exposures, 

and the potentially exposed or 

susceptible subpopulations EPA plans 

to consider in the risk evaluation (15 

U.S.C. 2605(b)(4)(D)). 

Development of the scope is the first 

step of a risk evaluation. The draft scope 

of the risk evaluation will include the 

following components (40 CFR 

702.41(c)): 

• The conditions of use, as 

determined by the Administrator, that 

EPA plans to consider in the risk 

evaluation. 

• The potentially exposed 

populations that EPA plans to evaluate; 

the ecological receptors that EPA plans 

to evaluate; and the hazards to health 

and the environment that EPA plans to 

evaluate. 

• A description of the reasonably 

available information and the science 

approaches that the Agency plans to 

use. 

• A conceptual model that will 

describe the actual or predicted 

relationships between the chemical 

substance, the conditions of use within 

the scope of the evaluation and the 

receptors, either human or 

environmental, with consideration of 

the life cycle of the chemical 

substance—from manufacturing, 

processing, distribution in commerce, 

use, to release or disposal—and 

identification of human and ecological 

health hazards EPA plans to evaluate for 

the exposure scenarios EPA plans to 

evaluate. 

• An analysis plan, which will 

identify the approaches and methods 

EPA plans to use to assess exposure, 

hazards, and risk, including associated 

uncertainty and variability, as well as a 

strategy for using reasonably available 

information and best available science 

approaches. 

• A plan for peer review. 

EPA encourages commenters to 

provide information they believe might 

be missing or may further inform the 

risk evaluation. EPA will publish a 

notice in the Federal Register 

announcing the availability of the final 

scope within three months of publishing 

the draft scope. 

IV. References 

The following is a listing of the 

documents that are specifically 

referenced in this Federal Register 

notice. The docket for this action 

includes these documents and other 

information considered by EPA, 

including documents that are referenced 

within the documents that are included 

in the docket. For assistance in locating 

these referenced documents, please 

consult the technical person listed 

under FOR FURTHER INFORMATION

CONTACT. 

1. EPA. Di-isodecyl Phthalate (DIDP) 

(1,2-Benzene-dicarboxylic acid, 1,2- 

diisodecyl ester); Manufacturer Request 

for Risk Evaluation Under the Toxic 

Substances Control Act (TSCA); Notice 

of Availability and Request for 

Comments. Federal Register. (84 FR 

42914, August 30, 2019) (FRL–9998–26). 

(Authority: 15 U.S.C. 2601 et seq.) 

Andrew Wheeler, 

Administrator. 

[FR Doc. 2020–26203 Filed 11–25–20; 8:45 am] 

BILLING CODE 6560–50–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10292 and CMS– 

R–65] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

January 26, 2021. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: 

CMS, Office of Strategic Operations 

and Regulatory Affairs, Division of 

Regulations Development, Attention: 

Document Identifier/OMB Control 

Number lllllll, Room C4–26– 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices 76079 

05, 7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html. 

2. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10292 State Medicaid HIT Plan, 

Planning Advance Planning 

Document, and Implementation 

Advance Planning Document for 

Section 4201 of the Recovery Act 

CMS–R–65 Final Peer Review 

Organizations Sanction Regulations 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: State Medicaid 

HIT Plan, Planning Advance Planning 

Document, and Implementation 

Advance Planning Document for 

Section 4201 of the Recovery Act; Use: 

To assess the appropriateness of state 

requests for the administrative Federal 

financial participation for expenditures 

under their Medicaid Electronic Health 

Record Incentive Program related to 

health information exchange, our staff 

will review the submitted information 

and documentation to make an approval 

determination of the state advance 

planning document. Form Number: 

CMS–10292 (OMB control number: 

0938–1088); Frequency: Once and 

occasionally; Affected Public: State, 

Local, and Tribal Governments; Number 

of Respondents: 56; Total Annual 

Responses: 56; Total Annual Hours: 

896. (For policy questions regarding this 

collection contact Edward Dolly at 410– 

786–8554.) 

2. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Final Peer 

Review Organizations Sanction 

Regulations; Use: The Peer Review 

Improvement Act of 1982 amended Title 

XI of the Social Security Act (the Act), 

creating the Utilization and Quality 

Control Peer Review Organization 

Program. Section 1156 of the Act 

imposes obligations on health care 

practitioners and others who furnish or 

order services or items under Medicare. 

This section also provides for sanction 

actions, if the Secretary determines that 

the obligations as stated by this section 

are not met. Quality Improvement 

Organizations (QIOs) are responsible for 

identifying violations. The QIOs may 

allow practitioners or other entities, 

opportunities to submit relevant 

information before determining that a 

violation has occurred. The information 

collection requirements contained in 

this information collection request are 

used by the QIOs to collect the 

information necessary to make their 

decision. Form Number: CMS–R–65 

(OMB control number: 0938–0444); 

Frequency: Occasionally; Affected 

Public: Private sector—Business or other 

for-profit and Not-for-profit institutions; 

Number of Respondents: 18; Total 

Annual Responses: 18; Total Annual 

Hours: 4,716. (For policy questions 

regarding this collection contact 

Kimberly Harris at 401–837–1118.) 

Dated: November 23, 2020. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2020–26223 Filed 11–25–20; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10443, CMS– 

10558 and CMS–287–21] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS) 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by December 28, 2020. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain . Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html 


jbell on DSKJLSW7X2PROD with NOTICES